The CEO of Flow Neuroscience has called out the US Food and Drug Administration (FDA) for market entry delays for clinically ...

Danish medtech Brainreader has secured $7.3m (€6.6m) to support the market rollout of Neuroreader, its artificial ...

SAGA Diagnostics has commercially launched the multi-cancer molecular residual disease (MRD) platform, Pathlight, in the US.

Salvia BioElectronics has raised €53m ($60m) in Series B funding towards advancing its non-invasive approach to treating chronic migraines.

Surgify Medical has secured €7m ($7.97m) in Series A funding to expand the reach of its Surgify Halo technology.

With the 78th World Health Assembly ending today, all eyes have been on this year’s World Health Organization (WHO) member’s ...

SeekIn has announced the clinical validation of its SeekInCare blood test, intended for the early identification of various ...

Neurostimulation is reshaping the treatment of urinary incontinence, offering minimally invasive relief through smarter and ...

Zylox-Tonbridge Medical Technology has received regulatory approval for its ZYLOX Unicorn vascular closure device (VCD) in ...

A team at the University of Melbourne has developed a new blood test for the diagnosis of rare genetic diseases in babies and ...

Researchers at the University of Colorado (CU) Anschutz Medical Campus, US, have developed the Colorado Limb Donning-Timed Up ...

Roche is set to partner with Broad Clinical Labs for developing pilot applications leveraging its next-generation sequencing ...